Literature DB >> 19536067

Global economic and health benefits of tobacco control: part 1.

H Wipfli1, J M Samet.   

Abstract

Although the risks of tobacco smoking have been known for decades, the pandemic of tobacco use continues. There are an estimated 1.3 billion smokers worldwide, along with millions more using various oral tobacco products. Recent global estimates place the mortality burden from tobacco use at over 6 million annually, with nearly two-thirds of these deaths occurring in developing countries. If current patterns persist, there will be an estimated 1 billion deaths from tobacco during the twenty-first century. Part 1 of this two-part paper provides an overview of the tobacco pandemic, the scope of the pandemic, and its economic and health consequences. Part 2 reviews the history of tobacco control to date and addresses the current global strategy, based on the World Health Organization's (WHO's) Framework Convention on Tobacco Control and the MPOWER package of interventions. Part 2 ends with a consideration of scenarios for the future of the pandemic.

Entities:  

Mesh:

Year:  2009        PMID: 19536067     DOI: 10.1038/clpt.2009.93

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  35 in total

1.  Putting the greater dimensions of obesity into perspective.

Authors:  Johannes Hebebrand
Journal:  Obes Facts       Date:  2010-12-16       Impact factor: 3.942

Review 2.  The effects of smoke carcinogens on bone.

Authors:  Carol Yan; Narayan G Avadhani; Jameel Iqbal
Journal:  Curr Osteoporos Rep       Date:  2011-12       Impact factor: 5.096

3.  Impact of Dietary and Metabolic Risk Factors on Cardiovascular and Diabetes Mortality in South Asia: Analysis From the 2010 Global Burden of Disease Study.

Authors:  Mohammad Y Yakoob; Renata Micha; Shahab Khatibzadeh; Gitanjali M Singh; Peilin Shi; Habibul Ahsan; Nagalla Balakrishna; Ginnela N V Brahmam; Yu Chen; Ashkan Afshin; Saman Fahimi; Goodarz Danaei; John W Powles; Majid Ezzati; Dariush Mozaffarian
Journal:  Am J Public Health       Date:  2016-10-13       Impact factor: 9.308

4.  Occupational metal exposures, smoking and risk of diabetes and prediabetes.

Authors:  A Yang; N Cheng; H Pu; S Liu; M Dai; T Zheng; Y Bai
Journal:  Occup Med (Lond)       Date:  2016-07-14       Impact factor: 1.611

5.  Patterns of tobacco use and tobacco-related psychiatric morbidity and substance use among middle-aged and older adults in the United States.

Authors:  Dan G Blazer; Li-Tzy Wu
Journal:  Aging Ment Health       Date:  2012-01-31       Impact factor: 3.658

6.  Family Beliefs and Behaviors About Smoking and Young Children's Secondhand Smoke Exposure.

Authors:  Marisa E Hilliard; Kristin A Riekert; Melbourne F Hovell; Cynthia S Rand; Josie S Welkom; Michelle N Eakin
Journal:  Nicotine Tob Res       Date:  2014-12-05       Impact factor: 4.244

7.  Perception on the Relationship between Cancer and Usage of Tobacco and Alcohol in Hail, Saudi Arabia.

Authors:  Ibrahim Abdelmageed Ginawi
Journal:  J Clin Diagn Res       Date:  2013-09-17

8.  Cigarette smoke exposure inhibits contact hypersensitivity via the generation of platelet-activating factor agonists.

Authors:  Ravi P Sahu; Irina Petrache; Mary J Van Demark; Badri M Rashid; Jesus A Ocana; Yuxuan Tang; Qiaofang Yi; Matthew J Turner; Raymond L Konger; Jeffrey B Travers
Journal:  J Immunol       Date:  2013-01-25       Impact factor: 5.422

9.  Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes.

Authors:  Jameel Iqbal; Li Sun; Jay Cao; Tony Yuen; Ping Lu; Itai Bab; N Adrian Leu; Satish Srinivasan; Sagie Wagage; Christopher A Hunter; Daniel W Nebert; Mone Zaidi; Narayan G Avadhani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

10.  Smoking, an additional risk factor in elder women with primary open-angle glaucoma.

Authors:  Vicente Zanon-Moreno; Jose J Garcia-Medina; Vicente Zanon-Viguer; Maria A Moreno-Nadal; Maria D Pinazo-Duran
Journal:  Mol Vis       Date:  2009-12-31       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.